Marcie A. Goldstein

Davis Polk advised the joint book-running managers in connection with a $115.1 million SEC-registered offering of 5,479,750 ordinary shares of Theravance Biopharma, Inc. The ordinary shares…

Davis Polk advised the joint book-running managers and representatives of the several underwriters on the $531 million initial public offering by Red Rock Resorts Inc. of 27,250,000 shares…

Davis Polk advised the joint book-running managers and representatives of the several underwriters on the $112 million initial public offering by SecureWorks Corp. of 8,000,000 shares of…

Davis Polk advised the sole underwriter in connection with the approximately $200 million secondary offering of 10,000,000 shares of common stock of Summit Materials, Inc. by certain…

Davis Polk advised the joint book-running managers and representatives of the several underwriters on the $54.8 million initial public offering by Aeglea BioTherapeutics, Inc. Aeglea’s…

Davis Polk advised the representatives of the several underwriters, in connection with a secondary offering of 18,975,000 shares of Class A common stock of GoDaddy Inc. by certain of…

Davis Polk advised the joint book-running managers and representatives of the several underwriters in the $70.5 million initial public offering by Corvus Pharmaceuticals, Inc. of 4,700,000…

Davis Polk advised the joint book-running managers and representatives of the underwriters in connection with an SEC-registered offering by Fluor Corporation of €500 million aggregate…

Davis Polk advised the sole underwriter in connection with the SEC-registered follow-on public offering of 4,444,445 ordinary shares sold by Quotient Limited (“Quotient”). Total gross…

Davis Polk advised the joint book-running managers and representatives of the underwriters in the $182.2 million initial public offering by BeiGene, Ltd. of 7,590,000 American Depositary…